Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018126369) HUMANIZED ANTI-CD19 ANTIBODY AND USE THEREOF WITH CHIMERIC ANTIGEN RECEPTOR
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/126369 International Application No.: PCT/CN2017/070208
Publication Date: 12.07.2018 International Filing Date: 05.01.2017
IPC:
A61K 39/395 (2006.01) ,C07K 16/28 (2006.01) ,A61P 35/00 (2006.01)
[IPC code unknown for A61K 39/395][IPC code unknown for C07K 16/28][IPC code unknown for A61P 35]
Applicants:
SHANGHAI SIDANSAI BIOTECHNOLOGY CO., LTD [CN/CN]; Room 201 Building 4, 998 Halei Road, Pudong New Area Shanghai 201203, CN
Inventors:
WU, Zhao; CN
LIU, Zhigang; CN
XIAO, Lei; CN
PU, Chengfei; CN
CAO, Zhiyuan; CN
Agent:
BEIJING JWT INTELLECTUAL PROPERTY CO., LTD.; Suite 801, Tower 2, SoBoss Center No. 16 South Sanhuan West Road Fengtai District, Beijing 100068, CN
Priority Data:
Title (EN) HUMANIZED ANTI-CD19 ANTIBODY AND USE THEREOF WITH CHIMERIC ANTIGEN RECEPTOR
(FR) ANTICORPS ANTI-CD19 HUMANISÉ ET SON UTILISATION AVEC UN RÉCEPTEUR D'ANTIGÈNE CHIMÈRE
Abstract:
(EN) Provided are humanized CD19 antibodies and disease treatment using the antibodies. A subject having a CD19 positive tumor may be administered a therapeutically effective amount of the humanized antibody.
(FR) L'invention concerne des anticorps CD19 humanisés et un traitement de maladie utilisant lesdits anticorps. Un sujet ayant une tumeur positive CD19 peut recevoir une quantité thérapeutiquement efficace de l'anticorps humanisé.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)